Chargement en cours...
Treatment options for patients with HR+/HER2− advanced breast cancer during the COVID-19 pandemic: dose reduction of ribociclib does not diminish efficacy
Enregistré dans:
| Publié dans: | Breast Cancer Res Treat |
|---|---|
| Auteur principal: | |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Springer US
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7239505/ https://ncbi.nlm.nih.gov/pubmed/32436148 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-020-05674-7 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|